Arteaga-Reyes Carmen, Sen Dwaipayan, Rudilosso Salvatore, Jouvent Eric, Hervé Dominique, Lindgren Arne G, Wardlaw Joanna M, Melkas Susanna, Doubal Fergus N
Row Fogo Centre for Research into Ageing and the Brain, and UK Dementia Research Institute, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Eur Stroke J. 2025 Jan 10:23969873241309506. doi: 10.1177/23969873241309506.
Cerebral small vessel disease (cSVD) is a highly prevalent disorder leading to physical, cognitive and functional decline. We report key barriers in the management of individuals with cSVD, the potential benefit of cSVD-dedicated health services, and evidence from existing models of care for adults with cSVD.
We examined information from a scientific seminar developed between seven experts in cSVD during the eighth European Stroke Organisation Conference that discussed the optimal health care for adults with cSVD and what health services dedicated to cSVD should include.
Barriers in cSVD care include unrecognised symptoms and modifiable risk factors, heterogeneity of clinical presentations, inefficient inter/intra-clinical services communication/organisation, and uncertainties regarding what assessments/treatments should be routinely done, when and by whom. However, existing health services and research studies suggest models of care in cSVD. Multi-step approaches can be used for identification and aetiological workup in individuals with cSVD, including basic and selected advanced evaluations, for example, monogenic cSVD testing. Although current guidelines for management of cSVD illlustrate limitations, there are recommendations on risk factors and lifestyle considerations, as well as pharmacological and non-pharmacological interventions for people with cSVD.
Existing healthcare models do not provide optimal care for individuals with cSVD. Lack of awareness of heterogeneous clinical presentations and uncertainty in threshold of cSVD 'burden' for referral to specialist multidisciplinary services, are key challenges for health services to overcome. Creating cSVD-dedicated services may prevent underdiagnosing and achieve standardised holistic management to improve outcomes in people with cSVD. However, adequate prevention and early management should be offered at all levels of care.
脑小血管病(cSVD)是一种高度常见的疾病,会导致身体、认知和功能衰退。我们报告了cSVD患者管理中的关键障碍、cSVD专项健康服务的潜在益处,以及现有cSVD成人护理模式的证据。
我们研究了在第八届欧洲卒中组织会议期间由七位cSVD专家开展的一次科学研讨会的信息,该研讨会讨论了cSVD成人的最佳医疗保健以及cSVD专项健康服务应包括的内容。
cSVD护理中的障碍包括未被识别的症状和可改变的风险因素、临床表现的异质性、临床服务间/内部沟通/组织效率低下,以及关于应常规进行哪些评估/治疗、何时进行以及由谁进行的不确定性。然而,现有的健康服务和研究表明了cSVD的护理模式。多步骤方法可用于cSVD患者的识别和病因检查,包括基本和选定的高级评估,例如单基因cSVD检测。尽管目前cSVD管理指南存在局限性,但对于cSVD患者的风险因素、生活方式考量以及药物和非药物干预有相关建议。
现有的医疗保健模式并未为cSVD患者提供最佳护理。对异质性临床表现缺乏认识以及转诊至专科多学科服务的cSVD“负担”阈值存在不确定性,是卫生服务需要克服的关键挑战。创建cSVD专项服务可能会防止漏诊,并实现标准化的整体管理,以改善cSVD患者的预后。然而,各级护理都应提供充分的预防和早期管理。